Given its colorectal cancer background, our HCT116-based NS-poly cell model may additionally harbor oncogenic drivers other than the NAB2-STAT6 fusion (e.g., KRASG13D mutation [34]), which could muddle the interpretation of HTS results. The gene discussed is NAB2; the disease is colorectal cancer.